Weekly or alternating week clinic visits, designed decades ago to detect either hypertension or suboptimal fetal growth, are imprecise, time-consuming, and, therefore, costly to deliver.26 The addition of PlGF testing to current gestational diabetes screening could rule out clinically significant early preterm birth with 99% NPV. This evidence concerns the gene PGF and Hypertension.